The largest database of trusted experimental protocols

Competitive radioimmunoassay

Manufactured by Linco Research

The Competitive Radioimmunoassay (cRIA) is a laboratory technique used to quantify the concentration of a specific analyte in a sample. It involves the competitive binding of the analyte and a radioactively labeled analyte to a limited number of antibody binding sites. The relative amounts of bound labeled and unlabeled analyte are measured, allowing for the determination of the analyte concentration in the original sample.

Automatically generated - may contain errors

2 protocols using competitive radioimmunoassay

1

Adiponectin Measurement Protocols in Cohort Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the GHS-prospective designs blood samples were collected between 8:00 and 9:00 AM after an overnight fast.
In the NHS and HPFS, blood samples were collected in EDTA blood tubes in the men and heparin blood tubes in the women, chilled, and sent back by prepaid overnight courier. Once in the laboratory, the samples were centrifuged and aliquoted into cryotubes as plasma, buffy coat, and red blood cells. Cryotubes were then stored in liquid nitrogen freezers at −130°C or lower [40 (link)].
In the GHS-prospective design, serum total and HMW adiponectin concentrations were measured by ELISA (Alpco, Salem, NH) as previously described [41 (link)]. The intra-assay coefficients of variation were 5.4 and 4.9, and 5.0 and 4.8% for total adiponectin and HMW adiponectin, respectively.
In the NHS and HPFS, plasma total adiponectin was measured separately, in two different laboratories, by competitive radioimmunoassay (Linco Research, St. Charles, MO). A similar coefficient of variation ranging 3-4%, was observed in both cohorts [42 (link)].
+ Open protocol
+ Expand
2

Inflammatory and Metabolic Biomarkers Assessed

Check if the same lab product or an alternative is used in the 5 most similar protocols
We assessed CRP, IL6, TNFαR2, and adiponectin as markers of inflammation. Moreover, C-peptide and TG/HDL were assessed as markers of hyperinsulinemia and insulin resistance, respectively.
The laboratory procedures were described in detail previously.33 (link), 34 Briefly, CRP was measured by a high sensitivity immunoturbidimetric assay (Denka Seiken Co, Tokyo, Japan). IL6 and TNFαR2 were measured by enzyme-linked immunosorbent assays (R&D systems, Minneapolis, MN). Adiponectin was measured with the use of a competitive radioimmunoassay (Linco Research, St. Charles, MO). C-peptide was measured using ELISA (Diagnostic Systems Laboratories/Beckman Coulter). TG and HDL were measured using standard methods with the use of reagents from Roche Diagnostics (Indianapolis, IN) and Genzyme (Cambridge, MA). The mean intra-assay coefficients of variation were <10% for all assays.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!